Case Report
Copyright ©The Author(s) 2025.
World J Clin Cases. May 6, 2025; 13(13): 100735
Published online May 6, 2025. doi: 10.12998/wjcc.v13.i13.100735
Figure 1
Figure 1 Time course of laboratory parameters associated with multiple organ failure after pegaspargase treatment. A: Aspartate aminotransferase (AST) and alanine aminotransferase (ALT); B: Total bilirubin (μmol/L); C: Alkaline phosphatase (ALP) (U/L), γ-Glutamyl transpeptidase (γ-GT) (U/L), and total bile acid (TBA) (μmol/L); D: Glomerular filtration rate (eGFR) (mL/min/1.72 m2); E: Hemoglobin (Hb) (g/L); F: Procalcitonin (PCT) (ng/mL) and C-reactive protein (CRP) (mg/L); G: Prothrombin (PT) time (s) and activated partial thromboplastin time (APTT) (s); H: International normalized ratio (INR); I: Alpha-fetoprotein (AFP) (IU/mL)over time after pegaspargase treatment.